|
Osteoporosis Market ForecastPublished by: Datamonitor Published: Jul. 17, 2009 - 82 Pages Table of Contents
AbstractIntroductionOsteoporosis continues to be an attractive therapy area for large pharmaceutical companies due to its high prevalence rate and unmet need. Globally, sales for osteoporosis drugs grew 7.0% year-on-year from 2004 to $9.6 billion in 2008 driven by strong performance of the bisphosphonate class. Reasons to Purchase
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||